Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy
- 1 July 2008
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 48 (3), 289-296
- https://doi.org/10.1097/qai.0b013e3181632cda
Abstract
It is unclear whether the ability to respond to vaccines is restored by antiretroviral therapy. We evaluated the influenza-specific immune responses elicited by a virosomal vaccine in HIV-infected children on long-term successful highly active antiretroviral therapy (HAART).This was an observational, prospective, open-label study enrolling 24 HIV-infected, HAART-treated (85 months' mean exposure), vaccine-naive children (median age=11.9 years) and 14 age- and gender-matched healthy controls. Mean CD4 T-cell counts (>900 cells/microL) and percentages (>37%) were comparable. The HIV RNA level was or=4-fold Ab titer raise in >40% of patients) and seroprotection (Ab titer>or=1:40 in >70% of patients) was achieved at 1 month in both groups; however, fewer HIV-infected children fulfilled these criteria. The A/H3N2- and A/H1N1-specific Ab geometric mean titers were lower in HIV-infected children compared with healthy controls at 1 and 6 months; interestingly, a boost in vaccine-specific IgG3 T helper 1 type Ab was seen in healthy controls alone. Finally, vaccine specific-IFNgamma- and IL-2-producing T lymphocytes were reduced at both time points in HIV-infected children compared with healthy controls.One injection of virosomal-adjuvanted influenza vaccine stimulates good immune responses, although the humoral and cellular immune responses are reduced in HIV-infected children compared to healthy children. This indicates that immunologic function impairments may persist upon HIV infection even if HIV-positive viremia is suppressed and immune recovery seems to be achieved.Keywords
This publication has 52 references indexed in Scilit:
- HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentThe Lancet, 2006
- Vaccine Supplement - PosttestVaccine, 2006
- Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 DiseaseThe Journal of Infectious Diseases, 2005
- Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infectionJournal of Allergy and Clinical Immunology, 2005
- Effect of Highly Active Antiretroviral Therapy on the Serological Response to Additional Measles Vaccinations in Human Immunodeficiency Virus-Infected ChildrenClinical Infectious Diseases, 2001
- Effect of HIV on Thymic Function before and after Antiretroviral Therapy in ChildrenThe Journal of Infectious Diseases, 2000
- Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virusThe Pediatric Infectious Disease Journal, 1997
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990
- Assembly of Greek Marble Inscriptions by Isotopic MethodsScience, 1978